Healthcare provider profile · identity verified

James A Morris, MD

Internal Medicine · WYNNEWOOD, PA · NPI 1912979923

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	164	20
Atorvastatin Calcium	Atorvastatin Calcium	136	21
Prednisone	Prednisone	128	15
Sertraline Hcl	Sertraline Hcl	121	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	117	11
Omeprazole	Omeprazole	117	12
Potassium Chloride	Potassium Chloride	116	15
Amlodipine Besylate	Amlodipine Besylate	112	12
Buspirone Hcl	Buspirone Hcl	99	12
Metoprolol Succinate	Metoprolol Succinate	91	suppressed
Mirtazapine	Mirtazapine	84	16
Lisinopril	Lisinopril	80	14
Furosemide	Furosemide	77	11
Metformin Hcl	Metformin Hcl	73	suppressed
Eliquis	Apixaban	71	13
Lorazepam	Lorazepam	71	15
Clopidogrel	Clopidogrel Bisulfate	69	suppressed
Xarelto	Rivaroxaban	66	suppressed
Losartan Potassium	Losartan Potassium	56	suppressed
Famotidine	Famotidine	53	suppressed
Duloxetine Hcl	Duloxetine Hcl	51	suppressed
Trazodone Hcl	Trazodone Hcl	50	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	48	11
Tramadol Hcl	Tramadol Hcl	35	suppressed
Creon	Lipase/Protease/Amylase	33	suppressed
Myrbetriq	Mirabegron	33	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	33	30
Levetiracetam	Levetiracetam	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Methimazole	Methimazole	31	suppressed
Spironolactone	Spironolactone	30	suppressed
Metolazone	Metolazone	29	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	28	suppressed
Torsemide	Torsemide	28	suppressed
Albuterol Sulfate	Albuterol Sulfate	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Topiramate	Topiramate	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Nystatin	Nystatin	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Alogliptin	Alogliptin Benzoate	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Jardiance	Empagliflozin	18	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Atenolol	Atenolol	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Lacosamide	Lacosamide	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	15	suppressed
Azithromycin	Azithromycin	14	suppressed
Budesonide	Budesonide	14	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Allopurinol	Allopurinol	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Clobazam	Clobazam	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Letrozole	Letrozole	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lactulose	Lactulose	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Triamterene	Triamterene	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error